Phase 2 IgA Nephropathy Clinical Trials
12 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–12 of 12 trials
Recruiting
Phase 2
Phase 2 Study of ADX-038 in Complement-Mediated Kidney Disease
IgA Nephropathy (IgAN)IgANC3G+2 more
ADARx Pharmaceuticals, Inc.45 enrolled29 locationsNCT06989359
Recruiting
Phase 2
Therapeutic Effect of Hydroxychloroquine on Immunoglobulin A (IgA) Nephropathy Course QUIgAN Study
IgA Nephropathy
Centre Hospitalier Universitaire de Saint Etienne334 enrolled7 locationsNCT06350630
Recruiting
Phase 2
A Study to Evaluate the Long-Term Safety and Efficacy of HSK39297 Tablets in Primary IgA Nephropathy
IgA Nephropathy (IgAN)
Haisco Pharmaceutical Group Co., Ltd.73 enrolled2 locationsNCT07616700
Recruiting
Phase 2
A Study of JADE101 in Participants With Immunoglobulin A Nephropathy
IgA Nephropathy
Jade Biosciences, Inc.30 enrolled7 locationsNCT07541287
Recruiting
Phase 2
Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of EVER001 in Participants With Selected Proteinuric Glomerular Diseases
Focal segmental glomerulosclerosis (FSGS)IgA Nephropathy (IgAN)Minimal Change Disease (MCD)
Everest Medicines (China) Co.,Ltd.45 enrolled2 locationsNCT07614477
Recruiting
Phase 2
A Study of SHR-2173 in Participants With Primary IgA Nephropathy
Primary IgA Nephropathy
Guangdong Hengrui Pharmaceutical Co., Ltd84 enrolled2 locationsNCT07354932
Recruiting
Phase 2
A Phase IIa Clinical Study of RG002C0106 Injection in Subjects With Primary IgA Nephropathy
IgA Nephropathy (IgAN)
Rigerna Therapeutics Co., Ltd.; Rigerna Therapeutics (Beijing) Co., Ltd.30 enrolled1 locationNCT07305974
Recruiting
Phase 2
Avacopan in Crescentic Immunoglobulin A Nephropathy (IgAN)
IgA Nephropathy (IgAN)
Mayo Clinic16 enrolled2 locationsNCT06676579
Recruiting
Phase 2
Monthly Dosing of Atacicept in IgAN
IgA Nephropathy (IgAN)Berger Disease
Vera Therapeutics, Inc.90 enrolled1 locationNCT07020923
Recruiting
Phase 2
Trial of the Impact of Sibeprenlimab on Immunoglobulin A Nephropathy Kidney Tissue
IgA Nephropathy
Otsuka Pharmaceutical Development & Commercialization, Inc.25 enrolled5 locationsNCT06740526
Recruiting
Phase 2
Phase II Study of Efficacy and Safety of HSK39297 Tablet in Treatment of Patients with Primary IgAN
IgA Nephropathy (IgAN)
Haisco Pharmaceutical Group Co., Ltd.80 enrolled2 locationsNCT06670352
Recruiting
Phase 2
Clinical Study of CM338 in the Treatment of Immunoglobulin A Nephropathy
IgA Nephropathy
Keymed Biosciences Co.Ltd70 enrolled1 locationNCT05775042